Low-grade follicular lymphomas: Analysis of prognosis in a series of 281 patients-Reference-Cited by-同舟云学术

Low-grade follicular lymphomas: Analysis of prognosis in a series of 281 patients

Published:1991-12 Issue:12 Volume:27 Page:1606-1613
ISSN:0277-5379
Container-title:European Journal of Cancer and Clinical Oncology
language:en
Short-container-title:European Journal of Cancer and Clinical Oncology

Author:

Soubeyran Pierre,Eghbali Houchingue,Bonichon Françoise,Trojani Monique,Richaud Pierre,Hœrni Bernard

Publisher

Elsevier BV

Subject

Oncology

Reference36 articles.

1. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas;Non-Hodgkin's Lymphoma Pathologic Classification Project,1982

2. Classification of non-Hodgkin's lymphomas;NCI non-Hodgkin's Classification Project Writing Committee,1985

3. Morphological subclassification of follicular lymphoma: variability of diagnoses among hemato-pathologists, a collaborative study between the repositor and pathology panel for lymphoma clinical studies;Metter;J Clin Oncol,1985

4. Molecular analysis of the t (14,18) chromosomal translocation in malignant lymphomas;Weiss;N Engl J Med,1987

5. Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t[14,18] translocation;Cleary;Cell,1986

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Past, present and future of prognostic scores in follicular lymphoma;Blood Reviews;2021-11

2. Impact of treatment in long-term survival patients with follicular lymphoma: A Spanish Lymphoma Oncology Group registry;PLOS ONE;2017-05-11

3. Follicular lymphoma patients with a high FLIPI score and a high tumor burden: A risk stratification model;Vojnosanitetski pregled;2015

4. ‘Watch and Wait’ as Initial Management for Patients with Follicular Lymphomas;BioDrugs;2012-12

5. Rituximab for the first-line treatment of stage III–IV follicular lymphoma (review of Technology Appraisal No. 110): a systematic review and economic evaluation.;Health Technology Assessment;2012-10